Viruses and oral cancer. Is there a link?

Microbes and Infection

Volumn 16, Issue 5, 2014, Pages 371-378

  Sand, Lars ^a   Jalouli, Jamshid ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Epstein Barr virus; Human herpes simplex virus type 1; Human papilloma virus; Oral cancer

Indexed keywords

BLOTTING; CANCER INCIDENCE; CANCER RISK; CARCINOGENESIS; DISEASE ASSOCIATION; DNA VIRUS; EPSTEIN BARR VIRUS; HERPES SIMPLEX VIRUS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HIGH RISK PATIENT; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFECTION RISK; LABORATORY; LOW RISK PATIENT; MIXED INFECTION; MOUTH CANCER; MOUTH SQUAMOUS CELL CARCINOMA; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SHORT SURVEY; SOUTHERN BLOTTING; SQUAMOUS CELL CARCINOMA; STOMATITIS; TONSIL CANCER; TUMOR VIRUS; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; VIRUS DETECTION; WART VIRUS; CARCINOMA, SQUAMOUS CELL; COMPLICATION; EPSTEIN BARR VIRUS INFECTION; HERPES SIMPLEX; MOUTH NEOPLASMS; VIROLOGY;

DNA VIRUSES; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 4; HUMAN PAPILLOMAVIRUS;

CARCINOMA, SQUAMOUS CELL; EPSTEIN-BARR VIRUS INFECTIONS; HERPES SIMPLEX; HUMANS; MOUTH NEOPLASMS; PAPILLOMAVIRUS INFECTIONS;

EID: 84901618492     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2014.02.009     Document Type: Short Survey

References (95)

1. Ellerman C., Bang O. Experimentelle Leukämie bei Hühnern. Cent Bakteriol 1908, 46:595-609.
2. Rous P. A sarcoma of the fowl transmissible by an agent separable from the tumor cells. J Exp Med 1911, 13:397-411.
3. Shope R. Serial transmission of virus of infectious papillomatosis in domestic rabbits. Proc Soc Exp Biol Med 1932, 32:830-832.
4. Groupe V., Manaker R. Discrete foci of altered chicken embryo cells associated with Rous sarcoma virus in tissue culture. Virology 1956, 2:838-840.
5. Temin H., Rubin H. Characteristics of an assay for Rous sarcoma virus and Rous sarcoma cells in tissue culture. Virology 1958, 6:669-688.
6. Yang Y.Y., Koh L.W., Tsai J.H., Tsai C.H., Wong E.F., Lin S.J., et al. Correlation of viral factors with cervical cancer in Taiwan. J Microbiol Immunol Infect 2004, 37:282-287.
7. Yang Y.Y., Koh L.W., Tsai J.H., Tsai C.H., Wong E.F., Lin S.J., et al. Involvement of viral and chemical factors with oral cancer in Taiwan. Jpn J Clin Oncol 2004, 34:176-183.
8. Al Moustafa A.E., Chen D., Ghabreau L., Akil N. Association between human papillomavirus and Epstein-Barr virus infections in human oral carcinogenesis. Med Hypotheses 2009, 73:184-186.
9. Jalouli J., Ibrahim S.O., Mehrotra R., Jalouli M.M., Sapkota D., Larsson P.A., et al. Prevalence of viral (HPV, EBV, HSV) infections in oral submucous fibrosis and oral cancer from India. Acta Otolaryngol 2010, 130:1306-1311.
10. Jalouli J., Ibrahim S.O., Sapkota D., Jalouli M.M., Vasstrand E.N., Hirsch J.M., et al. Presence of human papilloma virus, herpes simplex virus and Epstein-Barr virus DNA in oral biopsies from Sudanese patients with regard to toombak use. J Oral Pathol Med 2010, 39:599-604.
11. Schepman K., der Meij E., Smeele L., der Waal I. Concomitant leukoplakia in patients with oral squamous cell carcinoma. Oral Dis 1999, 5:206-209.
12. Noonan V.L., Kabani S. Diagnosis and management of suspicious lesions of the oral cavity. Otolaryngol Clin North Am 2005, 38:21-35.
13. Gupta P.C., Bhonsle R.B., Murti P.R., Daftary D.K., Mehta F.S., Pindborg J.J. An epidemiologic assessment of cancer risk in oral precancerous lesions in India with special reference to nodular leukoplakia. Cancer 1989, 63:2247-2252.
14. Proia N.K., Paszkiewicz G.M., Nasca M.A., Franke G.E., Pauly J.L. Smoking and smokeless tobacco-associated human buccal cell mutations and their association with oral cancer - a review. Cancer Epidemiol Biomarkers Prev 2006, 15:1061-1077.
15. Hirsch J.M., Wallstrom M., Carlsson A.P., Sand L. Oral cancer in Swedish snuff dippers. Anticancer Res 2012, 32:3327-3330.
16. Koh J., Cho N., Kong G., Lee J., Yoon K. p53 mutations and human papillomavirus DNA in oral squamous cell carcinoma: correlation with apoptosis. Br J Cancer 1998, 78:354-359.
17. Ibrahim S., Johannessen A., Idris A., Hirsch J., Vasstrand E., Magnusson B., et al. Immunohistochemical detection of p53 in non-malignant and malignant oral lesions associated with snuff dipping in the Sudan and Sweden. Int J Cancer 1996, 68:749-753.
18. Robinson M., Sloan P., Shaw R. Refining the diagnosis of oropharyngeal squamous cell carcinoma using human papillomavirus testing. Oral Oncol 2010, 46:492-496.
19. Dai M., Clifford G.M., le Calvez F., Castellsague X., Snijders P.J., Pawlita M., et al. Human papillomavirus type 16 and TP53 mutation in oral cancer: matched analysis of the IARC multicenter study. Cancer Res 2004, 64:468-471.
20. Benson E., Li R., Eisele D., Fakhry C. The clinical impact of HPV tumor status upon head and neck squamous cell carcinomas. Oral Oncol 2013 Oct 14, pii: S1368-8375(13)00691-X. http://dx.doi.org/10.1016/j.oraloncology.2013.09.008. [Epub ahead of print].
21. DeMonbreun W.A., Goodpasture E.W. Infectious oral papillomatosis of dogs. Am J Pathol 1932, 8(1):43-56.7.
22. Praetorius-Clausen F., Willis J. Papova virus-like particles in focal epithelial hyperplasia. Scand J Dent Res 1971, 79:362-365.
23. Jenson A., Lancaster W., Hartman D.-P., Schaffer E. Frequency and distribution of papillomavirus structural antigens in verrucae, multiple papillomas, an condylomata of the oral cavity. Am J Pathol 1982, 107:212-218.
24. zur Hausen H. Papillomavirus infections: a major cause of human cancers. Infection causing human cancer 2011, 145-243. Wiley-Blackwell, Weinheim. H. zur Hausen (Ed.).
25. John Doorbar, Kenneth Raj Biology of papillomavirus replication in infected epithelium. Future Virol 2007, 6:573-586. 10.2217/17460794.2.6.573.
26. Nagpal J.K., Patnaik S., Das B.R. Prevalence of high-risk human papilloma virus types and its association with P53 codon 72 polymorphism in tobacco addicted oral squamous cell carcinoma (OSCC) patients of Eastern India. Int J Cancer 2002, 97:649-653.
27. Fridman J.S., Lowe S.W. Control of apoptosis by p53. Oncogene 2003, 22:9030-9040.
28. Summersgill K., Smith E., Kirchner H., Haugen T., Turek L. p53 polymorphism, human papillomavirus infection in the oral cavity, and oral cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000, 90:334-339.
29. Murthy N., Mathew A. Risk factors for pre-cancerous lesions of the cervix. Eur J Cancer Prev 2000, 9:5-14.
30. Sellors J., Sankaranarayanan R. Colposcopy and treatment on cervical intraepithelial neoplasia: a beginners manual 2003, Lyon.
31. Syrjanen S., Lodi G., von Bultzingslowen I., Aliko A., Arduino P., Campisi G., et al. Human papillomaviruses in oral carcinoma and oral potentially malignant disorders: a systematic review. Oral Dis 2011, 17(Suppl. 1):58-72.
32. Gorsky M., Epstein J.B. Oral lichen planus: malignant transformation and human papilloma virus: a review of potential clinical implications. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011, 111:461-464.
33. Hillbertz N.S., Hirsch J.M., Jalouli J., Jalouli M.M., Sand L. Viral and molecular aspects of oral cancer. Anticancer Res 2012, 32:4201-4212.
34. Sugerman P., Shillitoe E. The high risk human papillomaviruses and oral cancer: evidence for and against a causal relationship. Oral Dis 1997, 3:130-147.
35. Al-Bakkal G., Ficarra G., McNeill K., Eversole L., Sterrantino G., Birek C. Human papilloma virus type 16 E6 gene expression in oral exophytic epithelial lesions as detected by in situ rtPCR. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999, 87:197-208.
36. Kreimer A.R., Clifford G.M., Boyle P., Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 2005, 14:467-475.
37. Cook M.B., Dawsey S.M., Freedman N.D., Inskip P.D., Wichner S.M., Quraishi S.M., et al. Sex disparities in cancer incidence by period and age. Cancer Epidemiol Biomarkers Prev 2009, 18:1174-1182.
38. Näsman A., Attner P., Hammarstedt L., Du J., Eriksson M., Giraud G., et al. Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma?. Int J Cancer 2009, 125(2):362-366. 10.1002/ijc.24339.
39. Pintos J., Black M.J., Sadeghi N., Ghadirian P., Zeitouni A.G., Viscidi R.P., et al. Human papillomavirus infection and oral cancer: a case-control study in Montreal, Canada. Oral Oncol 2008, 44:242-250.
40. Chaturvedi A.K., Engels E.A., Anderson W.F., Gillison M.L. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol 2008, 26:612-619.
41. Syrjanen S. HPV infections and tonsillar carcinoma. J Clin Pathol 2004, 57:449-455.
42. Tachezy R., Klozar J., Salakova M., Smith E., Turek L., Betka J., et al. HPV and other risk factors of oral cavity/oropharyngeal cancer in the Czech Republic. Oral Dis 2005, 11:181-185.
43. Chaturvedi A.K., Engels E.A., Pfeiffer R.M., Hernandez B.Y., Xiao W., Kim E., et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 2011, 29:4294-4301.
44. Bui T.C., Markham C.M., Ross M.W., Mullen P.D. Examining the association between oral health and oral HPV infection. Cancer Prev Res (Phila) 2013, 6:917-924.
45. Mannarini L., Kratochvil V., Calabrese L., Gomes Silva L., Morbini P., Betka J., et al. Human Papilloma Virus (HPV) in head and neck region: review of literature. Acta Otorhinolaryngol Ital 2009, 29:119-126.
46. zur Hausen H. Viruses in human cancers. Eur J Cancer 1999, 35:1174-1181.
47. Bussu F., Sali M., Gallus R., Vellone V.G., Zannoni G.F., Autorino R., et al. HPV infection in squamous cell carcinomas arising from different mucosal sites of the head and neck region. Is p16 immunohistochemistry a reliable surrogate marker?. Br J Cancer 2013, 108:1157-1162.
48. Stransky N., Egloff A.M., Tward A.D., Kostic A.D., Cibulskis K., Sivachenko A., et al. The mutational landscape of head and neck squamous cell carcinoma. Science 2011, 333:1157-1160.
49. Sand L., Jalouli J., Larsson P.A., Hirsch J.M. Human papilloma viruses in oral lesions. Anticancer Res 2000, 20:1183-1188.
50. Burkitt D. A sarcoma involving the jaws in African children. Br J Surg 1958, 46:218-223.
51. Burkitt D. A children's cancer depend on climate factors. Nature 1962, 194:232-234.
52. Epstein M., Barr Y. Cultivation invitro of human lymphoblasts from Burkitt's malignant lymphoma. Lancet 1964, 1:252-253.
53. Epstein M., Achong B., Barr Y. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 1964, 1:702-703.
54. Pillai M.R., Phanidhara A., Kesari A.L., Nair P., Nair M.K. Cellular manifestations of human papillomavirus infection in the oral mucosa. J Surg Oncol 1999, 71:10-15.
55. Rickinson A., Kieff E. Epstein-Barr virus. Fields virology 2001, Lippincott Williams & Wilkins Publishers, Philadelphia, Epstein-Barr Virus and Its Replication (Chapter 74), Chapter editors: Elliott Kieff and Alan B. Rickinson. B.N. Fields, P.M. Howley, D.E. Griffin, R.A. Lamb, M.A. Martin, B. Roizman, S.E. Straus, D.M. Knipe (Eds.).
56. Sample J., Young L., Martin B., Chatman T., Kieff E., Rickinson A., et al. Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes. J Virol 1990, 64:4084-4092.
57. Borza C.M., Hutt-Fletcher L.M. Alternate replication in B cells and epithelial cells switches tropism of Epstein-Barr virus. Nat Med 2002, 8:594-599.
58. Middleton T., Sugden B. Retention of plasmid DNA in mammalian cells is enhanced by binding of the Epstein-Barr virus replication protein EBNA1. J Virol 1994, 68:4067-4071.
59. Braz-Silva P.H., de Rezende N.P., Ortega K.L., de Macedo Santos R.T., de Magalhaes M.H. Detection of the Epstein-Barr virus (EBV) by in situ hybridization as definitive diagnosis of hairy leukoplakia. Head Neck Pathol 2008, 2:19-24.
60. Boulter A., Johnson N., Birnbaum W., Teo C. Epstein-Barr virus (EBV) associated lesions of the head and neck. Oral Dis 1996, 2:117-124.
61. Young L., Sample J., Sample C. Epstein-Barr virus (Herpesviridae). Encyclopedia of virology 1999, 487-501. Academic Press, San Diego, California. A. Granoff, R. Webster (Eds.).
62. Syrjanen S. Viral infections in oral mucosa. Scand J Dent Res 1992, 100:17-31.
63. Jalouli J., Jalouli M.M., Sapkota D., Ibrahim S.O., Larsson P.A., Sand L. Human papilloma virus, herpes simplex virus and Epstein Barr virus in oral squamous cell carcinoma from eight different countries. Anticancer Res 2012, 32:571-580.
64. Sand L., Wallstrom M., Jalouli J., Larsson P.A., Hirsch J.M. Epstein-Barr virus and human papillomavirus in snuff-induced lesions of the oral mucosa. Acta Otolaryngol 2000, 120:880-884.
65. Sand L.P., Jalouli J., Larsson P.A., Hirsch J.M. Prevalence of Epstein-Barr virus in oral squamous cell carcinoma, oral lichen planus, and normal oral mucosa. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002, 93:586-592.
66. Cruz I., Van den Brule A.J., Steenbergen R.D., Snijders P.J., Meijer C.J., Walboomers J.M., et al. Prevalence of Epstein-Barr virus in oral squamous cell carcinomas, premalignant lesions and normal mucosa - a study using the polymerase chain reaction. Oral Oncol 1997, 33:182-188.
67. Kis A., Feher E., Gall T., Tar I., Boda R., Toth E.D., et al. Epstein-Barr virus prevalence in oral squamous cell cancer and in potentially malignant oral disorders in an eastern Hungarian population. Eur J Oral Sci 2009, 117:536-540.
68. Mao E., Smith C. Detection of Epstein-Barr virus (EBV) DNA by the polymerase chain reaction (PCR) in oral smears from healthy individuals and patients with squamous cell carcinoma. J Oral Pathol Med 1993, 22:12-17.
69. Higa M., Kinjo T., Kamiyama K., Chinen K., Iwamasa T., Arasaki A., et al. Epstein-Barr virus (EBV)-related oral squamous cell carcinoma in Okinawa, a subtropical island, in southern Japan-simultaneously infected with human papillomavirus (HPV). Oral Oncol 2003, 39:405-414.
70. Shamaa A.A., Zyada M.M., Wagner M., Awad S.S., Osman M.M., Abdel Azeem A.A. The significance of Epstein Barr virus (EBV) & DNA topoisomerase II alpha (DNA-topo II alpha) immunoreactivity in normal oral mucosa, oral epithelial dysplasia (OED) and oral squamous cell carcinoma (OSCC). Diagn Pathol 2008, 3:45.
71. Schneweis K.E. [Serological relations of types 1 and 2 of Herpesvirus hominis to Herpesvirus simiae]. Z Immun Exp Ther 1962, 124:337-341.
72. Nahmias A.J., Dowdle W.R. Antigenic and biologic differences in herpesvirus hominis. Prog Med Virol 1968, 10:110-159.
73. Lucké B. Carcinoma in the leopard frog: its probable causation by a virus. J Exp Med 1938, 68(4):457-468.
74. Frenkel N., Roizman B., Cassai E., Nahmias A. A DNA fragment of Herpes simplex 2 and its transcription in human cervical cancer tissue. Proc Natl Acad Sci U S A 1972, 69:3784-3789.
75. Roizman B., Frenkel N. The transcription and state of herpes simplex virus DNA in productive infection and in human cervical cancer tissue. Cancer Res 1973, 33:1402-1416.
76. Wagner E., Sandri-Goldin R. Herpes simplex viruses: molecular biology, desk encyclopedia of general virology 2008, 460-468. Academic Press.
77. van Benthem B.H., Spaargaren J., van Den Hoek J.A., Merks J., Coutinho R.A., Prins M. Prevalence and risk factors of HSV-1 and HSV-2 antibodies in European HIV infected women. Sex Transm Infect 2001, 77:120-124.
78. Scott D.A., Coulter W.A., Lamey P.J. Oral shedding of herpes simplex virus type 1: a review. J Oral Pathol Med 1997, 26:441-447.
79. Roizman B., Knipe D. Herpes simplex viruses and their replication. Virology 2001, 2399-2459. Lippincott-Raven, Philadelphia. P. Howley, D. Knipe (Eds.).
80. Fleming D.T., McQuillan G.M., Johnson R.E., Nahmias A.J., Aral S.O., Lee F.K., et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 1997, 337:1105-1111.
81. Smith J.S., Herrero R., Bosetti C., Munoz N., Bosch F.X., Eluf-Neto J., et al. Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer. J Natl Cancer Inst 2002, 94:1604-1613.
82. Lehtinen M., Koskela P., Jellum E., Bloigu A., Anttila T., Hallmans G., et al. Herpes simplex virus and risk of cervical cancer: a longitudinal, nested case-control study in the Nordic countries. Am J Epidemiol 2002, 156:687-692.
83. Galloway D.A., McDougall J.K. The oncogenic potential of herpes simplex viruses: evidence for a 'hit-and-run' mechanism. Nature 1983, 302:21-24.
84. Southam C.M., Tanaka S., Arata T., Simkovic D., Miura M., Petropulos S.F. Enhancement of responses to chemical carcinogens by nononcogenic viruses and antimetabolites. Prog Exp Tumor Res 1969, 11:194-212.
85. Duff R., Rapp F. Oncogenic transformation of hamster embryo cells after exposure to inactivated herpes simplex virus type 1. J Virol 1973, 12:209-217.
86. Stich J.E., Li K.K., Chun Y.S., Weiss R., Park N.H. Effect of smokeless tobacco on the replication of herpes simplex virus invitro and on production of viral lesions in hamster cheek pouch. Arch Oral Biol 1987, 32:291-296.
87. Larsson P.A., Johansson S.L., Vahlne A., Hirsch J.M. Snuff tumorigenesis: effects of long-term snuff administration after initiation with 4-nitroquinoline-N-oxide and herpes simplex virus type 1. J Oral Pathol Med 1989, 18:187-192.
88. Hirsch J.M., Johansson S.L., Vahlne A. Effect of snuff and herpes simplex virus-1 on rat oral mucosa: possible associations with the development of squamous cell carcinoma. J Oral Pathol 1984, 13:52-62.
89. Cornella F.A., Saper C.D., Christensen R.E., Park N.H. Effect of DMBA on oral cancer development in hamsters with latent HSV-1 infections in trigeminal ganglia. Oral Surg Oral Med Oral Pathol 1989, 67:167-171.
90. Meurman J.H. Infectious and dietary risk factors of oral cancer. Oral Oncol 2010, 46:411-413.
91. Starr J.R., Daling J.R., Fitzgibbons E.D., Madeleine M.M., Ashley R., Galloway D.A., et al. Serologic evidence of herpes simplex virus 1 infection and oropharyngeal cancer risk. Cancer Res 2001, 61:8459-8464.
92. Parker T.M., Smith E.M., Ritchie J.M., Haugen T.H., Vonka V., Turek L.P., et al. Head and neck cancer associated with herpes simplex virus 1 and 2 and other risk factors. Oral Oncol 2006, 42:288-296.
93. Venuti A., Paolini F. HPV detection methods in head and neck cancer. Head Neck Pathol 2012, 6(Suppl. 1):S63-S74.
94. Celenligil H., Ebersole J. Characteristics and responses of EBV immortalized B cells from periodontal disease patients. Oral Dis 1997, 3:262-271.
95. Cobo F. Application of molecular diagnostic techniques for viral testing. Open Virol J 2012, 6:104-114.